Status:
NOT_YET_RECRUITING
the Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Gastrointestinal Dysfunction After Urological Laparoscopic Surgery
Lead Sponsor:
The First Affiliated Hospital of Xiamen University
Conditions:
Postoperative Gastrointestinal Dysfunction (POGD)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this clinical trial is to understand the effect of percutaneous acupoint electrical stimulation on postoperative gastrointestinal dysfunction. It will also investigate the safety of per...
Eligibility Criteria
Inclusion
- Age \> 18 years
- BMI \< 28 kg/m2
- ASA classification is I-III grade
- Preoperative pathological diagnosis is clear
- Laparoscopic surgury in urology under general anesthesia as a
- The patient has normal comprehension ability, and the patient or their family members can cooperate in filling out the questionnaire
- Voluntary to sign the informed consent form
Exclusion
- Not meeting the above standards
- Having severe heart, lung or cerebrovascular diseases (such as severe coronary heart diseases, valve diseases, respiratory failure, cerebral hemorrhage, cerebral infarction, etc.)
- Having taken analgesic and gastrointestinal motility drugs before the operation
- Contraindications for TEAS (having electronic devices in the body， skin damage or infection at the stimulation site)
- Previous history of TEAS or electro-acupuncture treatment
- Previous history of long-term gastrointestinal motility disorders
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT07133620
Start Date
September 1 2025
End Date
September 30 2026
Last Update
August 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.